AHRQ

Dear Research Advocate, "Never Settle" is the empowering guiding theme used by Janssen Pharmaceuticals to underscore the emphasis the company places on innovation to benefit patients. In my visit to their Spring House, PA, site today to participate in a worldwide town hall, I was struck by how their theme epitomizes the advocacy drive and determination of Research!America and all our partners in advocacy for research. I was glad to report to Janssen's teams that more and more members of Congress are championing research and innovation to benefit patients worldwide. Consider the comments of Chairman Roy Blunt (R-MO) about the FY16 Senate “Labor-H” appropriations draft, which reportedly...
The November 2015 issue of The Research Advocate is now online . Highlights from this month's issue include: The 2016 Advocacy Award recipients are announced. A federal policy update with details on the budget and appropriations agenda in Congress. Register for a webinar featuring AHRQ director, Dr. Kronick. A member spotlight featuring Shire. How you can be involved in Public Health Thank You Day on November 23. Download the entire November 2015 Research Advocate as a PDF.
Dear Research Advocate: Now that the President has signed off on the budget agreement, Appropriations Committee leadership is negotiating to establish the dollar level for each appropriations subcommittee to work with. Given the December 11 deadline for action, the committees are already working to set allocations for each federal agency and program. Here is a list of the Twitter handles for each House and Senate appropriator, along with suggested tweets. Please take a minute to tweet these leaders on why it is so important to increase funding for NIH, CDC, FDA, AHRQ and NSF; federal agencies that help keep the wheels of science and medical progress turning! It’s a mistake to just assume...
Over the course of his last few weeks before retiring, Speaker Boehner worked with fellow House and Senate leaders and the President to fashion a budget deal that increases the nation’s debt limit and provides an additional $80 billion above sequestration-level spending caps. Both non-defense and defense programs will receive $25 billion more in fiscal year 2016 (FY16) and $15 billion more in FY 2017. The House has passed this budget plan, and the Senate is expected to follow suit by Tuesday. See our statement . Passing this deal is step one. Step two is allocating top-line budget numbers across the 12 appropriations subcommittees (these allocations are known as “302(b)s”). This will likely...
Dear Research Advocate: Advocacy works. More members of Congress are speaking out in support of research, including at a Senate Labor-H Appropriations Subcommittee hearing featuring testimony from NIH Director Francis Collins and several NIH Institute Directors. Appropriations Committee Vice-Chairwoman Barbara Mikulski (D-MD) summed up the limitations created by the sequestration caps succinctly: “We cannot cap innovation, we cannot cap breakthroughs.” Labor-H Subcommittee Chairman Roy Blunt (R-MO) underscored the point that both the subcommittee and full appropriations committee support biomedical research as a high priority. The subcommittee’s Ranking Member Patty Murray (D-WA) spoke of...
Dear Research Advocate, The Nobel prize winners announced this week showcase the role of both private sector (William Campbell’s work at Merck) and federal funding (Paul Modrich’s and Aziz Sancar's NIH and NSF grants) in driving scientific progress, and more broadly, the profound return science delivers to our nation and the world. Read our statements on the winners . The next few weeks are crucial for science funding and policies. Congressional leadership is working with the President to arrive at a budget deal that lifts the sequester caps, allowing for increases in NIH and other research agencies. If a deal lifting the caps is not made before Speaker Boehner retires, the new speaker (...
Dear Research Advocate, A refreshing number of members of Congress have allocated time during this recess to champion medical research, among them Senators Capito (R-WV), Franken (D-MN), and Kirk (R-IL), and Representatives Burgess (R-TX-26), Dold (R-IL-10), Israel (D-NY-03), Lance (R-NJ-07) and Walden (R-OR-02). Rep. Dold, for example, visited Northwestern University Feinberg School of Medicine as well as private industries in his district, like Marathon, to discuss ways to speed up medical innovation. Visiting the genetics lab at Northwestern, Rep. Dold commented: “We spent a little over 330 billion dollars this year in treating diabetes alone. Can we get some [additional] research...
Dear Research Advocate: Research!America is proud to serve as a lead sponsor of the American Association for Cancer Research (AACR) Rally for Medical Research, a two-day event in Washington, DC next month. The Rally will unite individuals from across the medical research advocacy community to push for making National Institutes of Health (NIH) funding a higher national priority. Events begin on Wednesday, September 16 with an afternoon advocacy training and an evening congressional reception. On Thursday, after a breakfast featuring remarks by House Labor-HHS-Education Appropriations Subcommittee Chairman Tom Cole (R-OK-04), nearly 200 advocates will participate in Hill meetings. Add your...
Dear Research Advocate, This just in--the final version of the 21st Century Cures Act has been filed with the House Rules Committee in anticipation of a House vote next week. And to understate the news: it’s great!! The bill contains mandatory funding of $8.75 billion for the NIH Innovation Fund and $550 million for FDA. Compared to the version that passed the Energy and Commerce Committee, that’s $1.25 billion less for the Innovation Fund over five years. But considering what Reps. Upton (R-MI-06) and DeGette (D-CO-01) were up against in securing this supplemental funding stream, and thinking about what these dollars could mean for medical progress, the end result is a HUGE victory. Click...
Dear Research Advocate: There is a flurry of activity in Washington. Not only has the Supreme Court ruled on King v. Burwell , but the House and Senate Appropriations Committees have wrapped up consideration of their respective “Labor-H” appropriations bills, regular order we haven't seen for six years. The implications of the Supreme Court ruling are far-reaching, but one political effect could be a return to partisan gridlock in Congress. We can't let that get in the way of passage of 21st Century Cures Act. Please contact your representative in the House and ask them to champion 21st Century Cures. Whether or not they are among the 206 (!) bipartisan cosponsors to date, the more noise we...

Pages

Sidebar Quote

You can change the image of things to come. But you can’t do it sitting on your hands … The science community should reach out to Congress and build bridges.
The Honorable John E. Porter